missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse Lymphotoxin beta R/TNFRSF3 Fc Chimera
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 1008-LR-050
This item is not returnable.
View return policy
Description
The Recombinant Mouse Lymphotoxin beta R/TNFRSF3 Fc Chimera is derived from NS0. The Recombinant Mouse Lymphotoxin beta R/TNFRSF3 Fc Chimera has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 48.7 kDa (monomer) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| 17000 | |
| Lymphotoxin beta R/TNFRSF3 Fc Chimera | |
| Mouse myeloma cell line,NS0-derived mouse Lymphotoxin beta R/TNFRSF3 protein, (N-terminus) Mouse Lymphotoxin beta R (Ser28-Pro218) Accession &Num; P50284 IEGRMDP Mouse IgG2A (Glu98-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction